| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1418307-17-1 | (S)-Benzyl 2-((3-chloropyrazin-2-yl)methylcarbamoyl)pyrrolidine-1-carboxylate | C18H19ClN4O3 |
| 1418307-18-2 | (2S)-2-(8-Chloroimidazo(1,5-a)pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C18H17ClN4O2 |
| 1418308-27-6 | 6-Cyano-N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-1-(1-ethylpropyl)-1H-indole-4-carboxamide | C23H26N4O2 |
| 1418741-86-2 | 1,1'-(1,4-Phenylene)bis(1-(1,4'-bipiperidin)-1'-ylmethanone) | C28H42N4O2 |
| 1419075-88-9 | 4-(1,3,4-Oxadiazol-2-yl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester | C12H19N3O3 |
| 1419949-20-4 | N-Cyclopropylmethyl-2-(4-(4-methoxybenzoyl)piperidin-1-yl)-N-((4-oxo-3,5,7,8-tetrahydro-4H-pyrano(4,3-d)pyrimidin-2-yl)methyl)acetamide | C27H34N4O5 |
| 1420071-30-2 | Bioymifi;5-(5-(((5Z)-3-(4-Bromophenyl)-2-imino-4-oxo-5-thiazolidinylidene)methyl)-2-furanyl)-1H-isoindole-1,3(2H)-dione | C22H12BrN3O4S |
| 1420290-99-8 | 2-(2-Aminoethoxy)-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide hydrochloride (1:1) | C15H13Cl2N3O4.HCl |
| 1420477-60-6 | Acalabrutinib;4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide; ACP 196 | C26H23N7O2 |
| 1420478-87-0 | (2S)-2-(1-Bromo-8-chloroimidazo(1,5-a)pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C18H16BrClN4O2 |
| 1420478-88-1 | (S)-Benzyl 2-(8-amino-1-bromoimidazo(1,5-a)pyrazin-3-yl)pyrrolidine-1-carboxylate;benzyl (2S)-2-(8-amino-1-bromoimidazo(1,5-a)pyrazin-3-yl)pyrrolidine-1-carboxylate | C18H18BrN5O2 |
| 1420478-89-2 | (2S)-2-(8-Amino-1-(4-((2-pyridinylamino)carbonyl)phenyl)imidazo(1,5-a)pyrazin-3-yl)-1-pyrrolidinecarboxylic acid phenylmethyl ester | C30H27N7O3 |
| 1420478-90-5 | 4-(8-Amino-3-(2S)-2-pyrrolidinylimidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide | C22H21N7O |
| 1420623-75-1 | Imidazo(1,2-b)pyridazine-3-carboxylic acid ethyl ester | C9H9N3O2 |
| 1420685-39-7 | (4-Bromo-3-fluorophenyl)hydrazine hydrochloride | C6H6BrFN2.HCl |
| 1420800-16-3 | Oxetane-3-carbonitrile | C4H5NO |
| 1420987-86-5 | Brexpiprazole Impurity 1;1,4-Di(benzo(b)thiophen-4-yl)piperazine | C20H18N2S2 |
| 1420999-91-2 | N-(1-Acetyl-2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-chloro-3-pyridinecarboxamide | C18H18ClN3O2 |
| 1421227-52-2 | N-(6-(4-((((4-((4-Methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-4-pyrimidinyl)cyclopropanecarboxamide | C28H30F3N7O3 |
| 1421227-53-3 | 4-((6-((Cyclopropylcarbonyl)amino)-4-pyrimidinyl)oxy)-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)benzeneacetamide | C29H31F3N6O3 |
| 1421312-34-6 | 4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester | C18H15NO4 |
| 1421313-98-5 | 7-Oxo-2-azaspiro(4.5)decane-2-carboxylic acid 1,1-dimethylethyl ester | C14H23NO3 |
| 1421338-17-1 | 4-chloro-5-nitro-1-tosyl-1H-pyrrolo(2,3-b)pyridine | C14H10ClN3O4S |
| 1421341-05-0 | 3-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4(3H)-quinazolinone | C15H19BN2O3 |
| 1421372-66-8 | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)-1,2,4-benzenetriamine;Mutated EGFR-IN-1 | C25H31N7O |
| 1421372-67-9 | N1-(2-(Dimethylamino)ethyl)-5-methoxy-N1-methyl-N4-(4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)-2-nitro-1,4-benzenediamine | C25H29N7O3 |
| 1421372-94-2 | N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-2-pyrimidinamine | C20H16FN5O3 |
| 1421373-36-5 | 3-Chloro-N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)propanamide | C28H34ClN7O2 |
| 1421373-62-7 | N-(5-((5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl)amino)-2-((2-(dimethylamino)ethyl)methylamino)-4-methoxyphenyl)-2-propenamide;Mutant EGFR inhibitor | C27H30ClN7O2 |
| 1421373-65-0 | N-(2-((2-(Dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide;osimertinib | C28H33N7O2 |
| 1421373-66-1 | AZD-9291 mesylate;N-(2-((2-(Dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1) | C28H33N7O2.CH4O3S |
| 1421373-98-9 | N-(2-((2-(Dimethylamino)ethyl)methylamino)-5-((4-(1H-indol-3-yl)-2-pyrimidinyl)amino)-4-methoxyphenyl)-2-propenamide | C27H31N7O2 |
| 1421374-01-7 | 5-Methyl-2,5-diazaspiro(3.4)octane | C7H14N2 |
| 1421438-81-4 | N-((1S)-2-(((7S)-6,7-Dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido(3,2-a)(3)benzazepin-7-yl)amino)-1-methyl-2-oxoethyl)-4,4,4-trifluorobutanamide | C22H23F3N4O4 |
| 1421593-80-7 | N-Acetyl Lenalidomide;N-(2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-4-yl)acetamide | C15H15N3O4 |
| 1421599-34-9 | 4-(1,1'-Biphenyl)-4-yl-6-(4-bromophenyl)-2-phenylpyrimidine | C28H19BrN2 |
| 1421602-80-3 | 2,4-Dibromo-6-fluoro-3-pyridinol | C5H2Br2FNO |
| 1421783-64-3 | GZD 824;4-Methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)benzamide methanesulfonate (1:2) | C29H27F3N6O.2(CH4O3S) |
| 1421789-05-0 | 9,9'-Spirobi(9H-fluoren)-4-ylboronic acid | C25H17BO2 |
| 1421789-94-7 | 2-(Bromomethyl)pyrazine hydrobromide (1:1) | C5H5BrN2.HBr |
| 1421846-79-8 | 3-Methylisoxazole-4-boronic acid pinacol ester;3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | C10H16BNO3 |
| 1421919-75-6 | (2Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-1-(3,3-difluoro-1-azetidinyl)-2-propen-1-one | C16H10F8N4O |
| 1421923-86-5 | (2E)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-2-propenoic acid 2-(2-pyrazinyl)hydrazide | C17H11F6N7O |
| 1422144-42-0 | 2,4-Dimethylbenzoic acid (4-((1S)-1-(aminomethyl)-2-(6-isoquinolinylamino)-2-oxoethyl)phenyl)methyl ester methanesulfonate (1:2) | C28H27N3O3.2(CH4O3S) |
| 1422284-15-8 | (8R)-9-(6-Amino-9H-purin-9-yl)-8-methyl-5-(1-methylethoxy)-2,4,7-trioxa-5-phosphanonanoic acid 1-methylethyl ester 5-oxide 2-butenedioate (1:1) | C17H28N5O7P.C4H4O4 |
| 1422357-33-2 | Rotigotine EP Impurity G;(6S)-6-(bis(2-thiophen-2-ylethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol | C22H25NOS2 |
| 1422359-85-0 / 136379-59-4 | Fumonisin B3 | C34H59NO14 |
| 1422500-60-4 | Ziresovir;N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxo-3,5-dihydro-2H-1?6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine | C22H25N5O3S |
| 1422515-52-3 | Fexofenadine N-Oxide;1-(4-(4-(2-Carboxypropan-2-yl)phenyl)-4-hydroxybutyl)-4-(hydroxydiphenylmethyl)piperidine 1-oxide | C32H39NO5 |
| 1422619-13-3 | (3R,6E)-7-(4-(4-Fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3-hydroxy-5-oxo-6-heptenoic acid | C22H26FN3O6S |